Skip to content

Cancer-Related Fatigue Incidence and Associated Influencing Factors in Cancer Patients Prior to Radiotherapy: A Multicenter Cross-Sectional Survey Study

Cancer-Related Fatigue Incidence and Associated Influencing Factors in Cancer Patients Prior to Radiotherapy: A Multicenter Cross-Sectional Survey Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121523
Enrollment
Unknown
Registered
2026-03-31
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor

Interventions

Observation group:None

Sponsors

The Second Affiliated Hospital of Air Force Medical University, Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.Histologically or cytologically confirmed solid malignant tumor; 3.Scheduled to receive initial radical or adjuvant external beam radiotherapy; 4.Conscious and competent, without severe cognitive or mental disorders, capable of understanding and completing the questionnaire; 5.Voluntary participation with signed written informed consent.

Exclusion criteria

Exclusion criteria: 1.Prior history of cranial radiotherapy or presence of confirmed brain metastases (to avoid confounding effects of direct central nervous system involvement on fatigue assessment); 2.Severe non-malignant comorbidities expected to cause severe fatigue per se or significantly interfere with assessment (e.g., New York Heart Association Class IV heart failure, severe chronic obstructive pulmonary disease, etc.); 3.Currently enrolled in other interventional clinical trials with fatigue as the primary endpoint; 4.Any other conditions deemed by the investigators as unsuitable for participation in this study; 5.Cognitive impairment, language communication barriers, or psychiatric disorders that preclude understanding and completion of questionnaire assessment.

Design outcomes

Primary

MeasureTime frame
The anticipated incidence of moderate-to-severe cancer-related fatigue (defined as RPFS score >= 4 points) in this trial;

Secondary

MeasureTime frame
Age and gender;

Countries

China

Contacts

Public Contactshao qiuju

The Second Affiliated Hospital of Air Force Medical University, Chinese People's Liberation Army

shaoqj1966@163.com+86 189 9289 8513

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026